1991
DOI: 10.1007/bf01318202
|View full text |Cite
|
Sign up to set email alerts
|

Bile acids in human plasma interfere with cholecystokinin bioassay using dispersed pancreatic acini

Abstract: A bioassay using dispersed pancreatic acini was used to measure fasting plasma cholecystokinin (CCK) concentrations in 105 patients with various kinds of gastrointestinal diseases, 17 patients with diabetes mellitus, and 6 healthy volunteers. High plasma CCK bioactivities were observed in patients with obstructive jaundice, choledocolithiasis, and primary biliary cirrhosis. Twenty-three samples with high CCK bioactivities were assayed by the same bioassay after the addition of a specific CCK antagonist and by … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

1993
1993
2001
2001

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 10 publications
(2 citation statements)
references
References 19 publications
0
2
0
Order By: Relevance
“…It has also been suggested that the presence of endotoxins, a systemic increase in bile component levels [9], and liver dysfunction [10] may lead to anorexia. Miyasaka et al [11] reported that patients with obstructive jaundice presented increased cholecystokinin (CCK) concentrations. This hormone has powerful anorectic properties [12][13][14] and has been shown in experimental studies to reduce food intake [15,16].…”
mentioning
confidence: 99%
“…It has also been suggested that the presence of endotoxins, a systemic increase in bile component levels [9], and liver dysfunction [10] may lead to anorexia. Miyasaka et al [11] reported that patients with obstructive jaundice presented increased cholecystokinin (CCK) concentrations. This hormone has powerful anorectic properties [12][13][14] and has been shown in experimental studies to reduce food intake [15,16].…”
mentioning
confidence: 99%
“…Plasma CCK levels were assayed by radioimmunoassay using OAL-656, '251-labeled Bolton-Hunter CCK-33 as a tracer and CCK-8 as a standard. The antiserum specifically reacted with the aminoterminal region of CCK-8, and bound 100% of both CCK-8 and CCK-33 and 85% of CCK-39, but did not cross-react with the nonsulfated form of CCK-8, gastrin 17-1, or cerulein (20). …”
Section: Assaysmentioning
confidence: 94%